Binding of pro-prion to filamin A: By design or an unfortunate blunder

Oncogene

Volumn 29, Issue 39, 2010, Pages 5329-5345

  Li, C ^a   Xin, W ^b   Sy, M S ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Cancer; Filamins; Prion protein

Indexed keywords

FILAMIN A; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; PRION PROTEIN; ACTIN BINDING PROTEIN; CONTRACTILE PROTEIN; FILAMIN; GLYCOSYLPHOSPHATIDYLINOSITOL; PRION; PROTEIN BINDING; PROTEIN PRECURSOR;

CANCER CELL; CARCINOGENESIS; CELL FUNCTION; CELL MIGRATION; CELL SPREADING; CREUTZFELDT JAKOB DISEASE; HUMAN; KURU; MELANOMA CELL; NONHUMAN; PANCREAS CANCER; PRION DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SURVIVAL; X CHROMOSOME; CELL MEMBRANE; GENETICS; MELANOMA; METABOLISM; MORTALITY; PANCREAS CARCINOMA; PANCREAS TUMOR; PRION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL MEMBRANE; CONTRACTILE PROTEINS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; MELANOMA; MICROFILAMENT PROTEINS; PANCREATIC NEOPLASMS; PRIONS; PROTEIN BINDING; PROTEIN PRECURSORS; SIGNAL TRANSDUCTION; FILAMINS;

MAMMALIA;

EID: 77957552124     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.307     Document Type: Review

References (228)

1. Abujiang P, Mori TJ, Takahashi T, Tanaka F, Kasyu I, Hitomi S et al. (1998). Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers. Oncogene 17: 3029-3033.
2. Adamson R, Jones AS, Field JK. (1994). Loss of heterozygosity studies on chromosome 17 in head and neck cancer using microsatellite markers. Oncogene 9: 2077-2082.
3. Aguirre AJ, Brennan C, Bailey G, Sinha R, Feng B, Leo C et al. (2004). High-resolution characterization of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci USA 101: 9067-9072.
4. Akasaka T, van Leeuwen RL, Yoshinaga IG, Mihm Jr MC, Byers HR. (1995). Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines. J Invest Dermatol 105: 104-108
5. Alper O, Stetler-Stevenson WG, Harris LN, Leitner WW, Ozdemirli M, Hartmann D et al. (2009). Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma. Cancer Sci 100: 1748-1756.
6. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA et al. (2009). Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 41: 986-990.
7. Anantharam V, Kanthasamy A, Choi CJ, Martin DP, Latchoumycandane C, Richt JA et al. (2008). Opposing roles of prion protein in oxidative stress- and ER stress-induced apoptotic signaling. Free Radic Biol Med 45: 1530-1541.
8. Antonacopoulou AG, Grivas PD, Skarlas L, Kalofonos M, Scopa CD, Kalofonos HP. (2008). POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance? Anticancer Res 28: 1221-1227.
9. Argos M, Kibriya MG, Jasmine F, Olopade OI, Su T, Hibshoosh H et al. (2008). Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays. Cancer Genet Cytogenet 182: 69-74.
10. Awata H, Huang C, Handlogten ME,Miller RT. (2001). Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein. J Biol Chem 276: 34871-34879.
11. Bashyam MD, Bair R, Kim YH, Wang P, Hernandez-Boussard T, Karikari CA et al. (2005). Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia 7: 556-562.
12. Basler K, Oesch B, Scott M, Westaway D, Walchli M, Groth DF et al. (1986). Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46: 417-428.
13. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM et al. (2009). Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res 15: 788-796.
14. Bellanger JM, Astier C, Sardet C, Ohta Y, Stossel TP, Debant A. (2000). The Rac1- and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin. Nat Cell Biol 2: 888-892.
15. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P et al. (2001). Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 98: 13790-13795.
16. Bisgaard ML, Jager AC, Dalgaard P, Sondergaard JO, Rehfeld JF, Nielsen FC. (2001). Allelic loss of chromosome 2p21-16.3 is associated with reduced survival in sporadic colorectal cancer. Scand J Gastroenterol 36: 405-409.
17. Bolton DC, McKinley MP, Prusiner SB. (1982). Identification of a protein that purifies with the scrapie prion. Science 218: 1309-1311.
18. Borbiev T, Verin AD, Shi S, Liu F, Garcia JG. (2001). Regulation of endothelial cell barrier function by calcium/calmodulin-dependent protein kinase II. Am J Physiol Lung Cell Mol Physiol 280: L983-L990.
19. Boschman CR, Stryker S, Reddy JK, Rao MS. (1994). Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas. Am J Pathol 145: 1291-1295.
20. Bouffard D, Duncan LM, Howard CA, Mihm Jr MC, Byers HR. (1994). Actin-binding protein expression in benign and malignant melanocytic proliferations. Hum Pathol 25: 709-714.
21. Bounhar Y, Zhang Y, Goodyer CG, LeBlanc A. (2001). Prion protein protects human neurons against Bax-mediated apoptosis. J Biol Chem 276: 39145-39149.
22. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD et al. (2005). Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res 65: 8679-8689.
23. Brosh R, Rotter V. (2009). When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 9: 701-713.
24. Brown KM, Macgregor S, Montgomery GW, Craig DW, Zhao ZZ, Iyadurai K et al. (2008). Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet 40: 838-840.
25. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M et al. (1993). Mice devoid of PrP are resistant to scrapie. Cell 73: 1339-1347.
26. Byers HR, Etoh T, Doherty JR, Sober AJ, Mihm Jr MC. (1991). Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis. Am J Pathol 139: 423-435.
27. Calderwood DA, Huttenlocher A, Kiosses WB, Rose DM, Woodside DG, Schwartz MA et al. (2001). Increased filamin binding to betaintegrin cytoplasmic domains inhibits cell migration. Nat Cell Biol 3: 1060-1068.
28. Campana V, Sarnataro D, Zurzolo C. (2005). The highways and byways of prion protein trafficking. Trends Cell Biol 15: 102-111.
29. Castro P, Creighton CJ, Ozen M, Berel D, Mims MP, Ittmann M. (2009). Genomic profiling of prostate cancers from African American men. Neoplasia 11: 305-312.
30. Caughey B, Brown K, Raymond GJ, Katzenstein GE, Thresher W. (1994). Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red. J Virol 68: 2135-2141.
31. Chen R, Knez JJ, Merrick WC, Medof ME. (2001). Comparative efficiencies of C-terminal signals of native glycophosphatidylinositol (GPI)-anchored proproteins in conferring GPI-anchoring. J Cell Biochem 84: 68-83.
32. Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R. (2002). Cellular prion protein transduces neuroprotective signals. EMBO J 21: 3317-3326.
33. Choi YW, Bae SM, Kim YW, Lee HN, Kim YW, Park TC et al. (2007). Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis. Int J Gynecol Cancer 17: 687-696.
34. Creutzfeldt HG. (1920). Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems. Vorläufige Mitteilung. Zeitschrift fur die gesamte Neurologie und Psychiatrie 57: 1-18.
35. Cukier IH, Li Y, Lee JM. (2007). Cyclin B1/Cdk1 binds and phosphorylates Filamin A and regulates its ability to cross-link actin. FEBS Lett 581: 1661-1672.
36. Cunningham CC, Gorlin JB, Kwiatkowski DJ, Hartwig JH, Janmey PA, Byers HR et al. (1992). Actin-binding protein requirement for cortical stability and efficient locomotion. Science 255: 325-327.
37. Daley D, Lewis S, Platzer P, MacMillen M, Willis J, Elston RC et al. (2008). Identification of susceptibility genes for cancer in a genomewide scan: results from the colon neoplasia sibling study. Am J Hum Genet 82: 723-736.
38. Davies P, Brown DR. (2008). The chemistry of copper binding to PrP: is there sufficient evidence to elucidate a role for copper in protein function? Biochem J 410: 237-244.
39. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB. (2008). Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18: 54-61.
40. Devilee P, Cornelisse CJ, Kuipers-Dijkshoorn N, Jonker C, Pearson PL. (1990). Loss of heterozygosity on 17p in human breast carcinomas: defining the smallest common region of deletion. Cytogenet Cell Genet 53: 52-54.
41. Dimova I, Orsetti B, Negre V, Rouge C, Ursule L, Lasorsa L et al. (2009). Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array CGH analysis. Tumori 95: 357-366.
42. Dohna M, Reincke M, Mincheva A, Allolio B, Solinas-Toldo S, Lichter P. (2000). Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications. Genes Chromosomes Cancer 28: 145-152.
43. Donne DG, Viles JH, Groth D, Mehlhorn I, James TL, Cohen FE et al. (1997). Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci USA 94: 13452-13457.
44. Douglas EJ, Fiegler H, Rowan A, Halford S, Bicknell DC, Bodmer W et al. (2004). Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res 64: 4817-4825.
45. Edenhofer F, Rieger R, Famulok M, Wendler W, Weiss S, Winnacker EL. (1996). Prion protein PrPc interacts with molecular chaperones of the Hsp60 family. J Virol 70: 4724-4728.
46. Fang X, Zheng P, Tang J, Liu Y. (2010). CD24: from A to Z. Cell Mol Immunol 7: 100-103.
47. Fanjul M, Alvarez L, Hollande E. (2007). Expression and subcellular localization of a 35-kDa carbonic anhydrase IV in a human pancreatic ductal cell line (Capan-1). J Histochem Cytochem 55: 783-794.
48. Fanjul M, Alvarez L, Salvador C, Gmyr V, Kerr-Conte J, Pattou F et al. (2004). Evidence for a membrane carbonic anhydrase IV anchored by its C-terminal peptide in normal human pancreatic ductal cells. Histochem Cell Biol 121: 91-99.
49. Feng S, Resendiz JC, Lu X, Kroll MH. (2003). Filamin A binding to the cytoplasmic tail of glycoprotein Ibalpha regulates von Willebrand factor-induced platelet activation. Blood 102: 2122-2129.
50. Feng Y, Chen MH, Moskowitz IP, Mendonza AM, Vidali L, Nakamura F et al. (2006). Filamin A (FLNA) is required for cellcell contact in vascular development and cardiac morphogenesis. Proc Natl Acad Sci USA 103: 19836-19841.
51. Feng Y, Walsh CA. (2004). The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol 6: 1034-1038.
52. Fiori JL, Zhu TN, OConnell MP, Hoek KS, Indig FE, Frank BP et al. (2009). Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells. Endocrinology 150: 2551-2560.
53. Fox JW, Lamperti ED, Eksioglu YZ, Hong SE, Feng Y, Graham DA et al. (1998). Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron 21: 1315-1325.
54. Franscini N, El Gedaily A, Matthey U, Franitza S, Sy MS, Burkle A et al. (2006). Prion protein in milk. PLoS One 1: e71.
55. Frierson Jr HF, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J et al. (2002). Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 161: 1315-1323.
56. Fujita Y, Sakakura C, Shimomura K, Nakanishi M, Yasuoka R, Aragane H et al. (2003). Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Hepatogastroenterology 50: 1857-1863.
57. Gabus C, Auxilien S, Pechoux C, Dormont D, Swietnicki W, Morillas M et al. (2001). The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. J Mol Biol 307: 1011-1021.
58. Gajdusek DC. (2008). Review. Kuru and its contribution to medicine. Philos Trans R Soc Lond B Biol Sci 363: 3697-3700.
59. Gajdusek DC, Zigas V. (1957). Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population. N Engl J Med 257: 974-978.
60. Garcea G, Neal CP, Pattenden CJ, Steward WP, Berry DP. (2005). Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 41: 2213-2236.
61. Ginsberg MH, Partridge A, Shattil SJ. (2005). Integrin regulation. Curr Opin Cell Biol 17: 509-516.
62. Glogauer M, Arora P, Chou D, Janmey PA, Downey GP, McCulloch CA. (1998). The role of actin-binding protein 280 in integrindependent mechanoprotection. J Biol Chem 273: 1689-1698.
63. Goeze A, Schluns K, Wolf G, Thasler Z, Petersen S, Petersen I. (2002). Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J Pathol 196: 8-16.
64. Goldfarb LG, Brown P, Cervenakova L, Gajdusek DC. (1994). Genetic analysis of Creutzfeldt-Jakob disease and related disorders. Philos Trans R Soc Lond B Biol Sci 343: 379-384.
65. Goldmann WH. (2002). p56(lck) Controls phosphorylation of filamin (ABP-280) and regulates focal adhesion kinase (pp125(FAK)). Cell Biol Int 26: 567-571.
66. Gorlin JB, Yamin R, Egan S, Stewart M, Stossel TP, Kwiatkowski DJ et al. (1990). Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring. J Cell Biol 111: 1089-1105.
67. Greig JR. (1950). Scrapie in sheep. J Comp Pathol 60: 263-266
68. Guan XY, Meltzer PS, Dalton WS, Trent JM. (1994). Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat Genet 8: 155-161.
69. Guan Y, Hata N, Kuga D, Yoshimoto K, Mizoguchi M, Shono T et al. (2008). Narrowing of the regions of allelic losses of chromosome 1p36 in meningioma tissues by an improved SSCP analysis. Int J Cancer 122: 1820-1826.
70. Guedj N, Zhan Q, Perigny M, Rautou PE, Degos F, Belghiti J et al. (2009). Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas. J Hepatol 51: 93-101.
71. Guled M, Myllykangas S, Frierson Jr HF, Mills SE, Knuutila S, Stelow EB. (2008). Array comparative genomic hybridization analysis of olfactory neuroblastoma. Mod Pathol 21: 770-778.
72. Guo Z, Linn JF, Wu G, Anzick SL, Eisenberger CF, Halachmi S et al. (2004). CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer. Nat Med 10: 374-381.
73. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, Von Hoff DD. (2002). Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 62: 2890-2896.
74. Hart AW, Morgan JE, Schneider J, West K, McKie L, Bhattacharya S et al. (2006). Cardiac malformations and midline skeletal defects in mice lacking filamin A. Hum Mol Genet 15: 2457-2467.
75. He HJ, Kole S, Kwon YK, Crow MT, Bernier M. (2003). Interaction of filamin A with the insulin receptor alters insulin-dependent activation of the mitogen-activated protein kinase pathway. J Biol Chem 278: 27096-27104.
76. He X, Li Y, Schembri-King J, Jakes S, Hayashi J. (2000). Identification of actin binding protein, ABP-280, as a binding partner of human Lnk adaptor protein. Mol Immunol 37: 603-612.
77. Hegde RS, Rane NS. (2003). Prion protein trafficking and the development of neurodegeneration. Trends Neurosci 26: 337-339.
78. Helfand BT, Loeb S, Meeks JJ, Fought AJ, Kan D, Catalona WJ. (2009). Pathological outcomes associated with the 17q prostate cancer risk variants. J Urol 181: 2502-2507.
79. Herlyn M. (2006). Molecular targets in melanoma: strategies and challenges for diagnosis and therapy. Int J Cancer 118: 523-526.
80. Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. (2006). Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 20: 1218-1249.
81. Hidaka S, Yasutake T, Kondo M, Takeshita H, Yano H, Haseba M et al. (2003). Frequent gains of 20q and losses of 18q are associated with lymph node metastasis in intestinal-type gastric cancer. Anticancer Res 23: 3353-3357.
82. Hirai M, Yoshida S, Kashiwagi H, Kawamura T, Ishikawa T, Kaneko M et al. (1999). 1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment. Genes Chromosomes Cancer 25: 261-269.
83. Ho JC, Cheung ST, Patil M, Chen X, Fan ST. (2006). Increased expression of glycosyl-phosphatidylinositol anchor attachment protein 1 (GPAA1) is associated with gene amplification in hepatocellular carcinoma. Int J Cancer 119: 1330-1337.
84. Hoggard N, Hey Y, Brintnell B, James L, Jones D, Mitchell E et al. (1995). Identification and cloning in yeast artificial chromosomes of a region of elevated loss of heterozygosity on chromosome 1p31.1 in human breast cancer. Genomics 30: 233-243.
85. Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, Boivin GP et al. (2006). Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 66: 95-106.
86. Hruban RH, Zamboni G. (2009). Pancreatic cancer. Special issue- insights and controversies in pancreatic pathology. Arch Pathol Lab Med 133: 347-349.
87. Hsiao K, Prusiner SB. (1990). Inherited human prion diseases. Neurology 40: 1820-1827.
88. Hulsebos TJ, Bijleveld EH, Oskam NT, Westerveld A, Leenstra S, Hogendoorn PC et al. (1997). Malignant astrocytoma-derived region of common amplification in chromosomal band 17p12 is frequently amplified in high-grade osteosarcomas. Genes Chromosomes Cancer 18: 279-285.
89. Hynes RO. (2002). Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687.
90. Ikezawa H. (2002). Glycosylphosphatidylinositol (GPI)-anchored proteins. Biol Pharm Bull 25: 409-417.
91. Ishihara T, Tsuda H, Hotta A, Kozaki K, Yoshida A, Noh JY et al. (2008). ITCH is a putative target for a novel 20q11.22 amplification detected in anaplastic thyroid carcinoma cells by array-based comparative genomic hybridization. Cancer Sci 99: 1940-1949.
92. Ishkanian AS, Mallof CA, Ho J, Meng A, Albert M, Syed A et al. (2009). High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer. Prostate 69: 1091-1100.
93. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. (2007). Cancer statistics, 2007. CA Cancer J Clin 57: 43-66.
94. Jiang WW, Zahurak M, Zhou ZT, Park HL, Guo ZM, Wu GJ et al. (2007). Alterations of GPI transamidase subunits in head and neck squamous carcinoma. Mol Cancer 6: 74.
95. Johnson-Pais TL, Nellissery MJ, Ammerman DG, Pathmanathan D, Bhatia P, Buller CL et al. (2003). Determination of a minimal region of loss of heterozygosity on chromosome 18q21.33 in osteosarcoma. Int J Cancer 105: 285-288.
96. Jonson T, Gorunova L, Dawiskiba S, Andren-Sandberg A, Stenman G, ten Dijke P et al. (1999). Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer. Genes Chromosomes Cancer 24: 62-71.
97. Kamochi N, Nakashima M, Aoki S, Uchihashi K, Sugihara H, Toda S et al. (2008). Irradiated fibroblast-induced bystander effects on invasive growth of squamous cell carcinoma under cancer-stromal cell interaction. Cancer Sci 99: 2417-2427.
98. Katoh H, Shibata T, Kokubu A, Ojima H, Loukopoulos P, Kanai Y et al. (2005). Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome. J Hepatol 43: 863-874.
99. Kayed H, Kleeff J, Keleg S, Siang X, Penzel R, Giese T et al. (2006). Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma. Int J Oncol 29: 1139-1148.
100. Keshamouni VG, Michailidis G, Grasso CS, Anthwal S, Strahler JR, Walker A et al. (2006). Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelialmesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res 5: 1143-1154.
101. Keshet GI, Bar-Peled O, Yaffe D, Nudel U, Gabizon R. (2000). The cellular prion protein colocalizes with the dystroglycan complex in the brain. J Neurochem 75: 1889-1897.
102. Kiema T, Lad Y, Jiang P, Oxley CL, Baldassarre M, Wegener KL et al. (2006). The molecular basis of filamin binding to integrins and competition with talin. Mol Cell 21: 337-347.
103. Kim H, Sengupta A, Glogauer M, McCulloch CA. (2008). Filamin A regulates cell spreading and survival via beta1 integrins. Exp Cell Res 314: 834-846.
104. Kim JH, Dhanasekaran SM, Mehra R, Tomlins SA, Gu W, Yu J et al. (2007a). Integrative analysis of genomic aberrations associated with prostate cancer progression. Cancer Res 67: 8229-8239. (Pubitemid 47395160)
105. Kim SW, Kim JW, Kim YT, Kim JH, Kim S, Yoon BS et al. (2007b). Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: potential predictive markers of chemoresistant disease. Genes Chromosomes Cancer 46: 1-9.
106. Kimmelman AC, Hezel AF, Aguirre AJ, Zheng H, Paik JH, Ying H et al. (2008). Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci USA 105: 19372-19377.
107. Kinoshita T, Fujita M, Maeda Y. (2008). Biosynthesis, remodelling and functions of mammalian GPI-anchored proteins: recent progress. J Biochem 144: 287-294.
108. Kley RA, Hellenbroich Y, van der Ven PF, Furst DO, Huebner A, Bruchertseifer V et al. (2007). Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain 130: 3250-3264.
109. Krakow D, Robertson SP, King LM, Morgan T, Sebald ET, Bertolotto C et al. (2004). Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis. Nat Genet 36: 405-410.
110. Kresse SH, Berner JM, Meza-Zepeda LA, Gregory SG, Kuo WL, Gray JW et al. (2005). Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH. Mol Cancer 4: 39.
111. Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y et al. (1999). Prions prevent neuronal cell-line death. Nature 400: 225-226.
112. Lad Y, Kiema T, Jiang P, Pentikainen OT, Coles CH, Campbell ID et al. (2007). Structure of three tandem filamin domains reveals auto-inhibition of ligand binding. EMBO J 26: 3993-4004.
113. Larramendy ML, Lushnikova T, Bjorkqvist AM, Wistuba II, Virmani AK, Shivapurkar N et al. (2000). Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines. Cancer Genet Cytogenet 119: 132-138.
114. Leonardi A, Ellinger-Ziefelbauer H, Franzoso G, Brown K, Siebenlist U. (2000). Physical and functional interaction of filamin (actinbinding protein-280) and tumor necrosis factor receptor-associated factor 2. J Biol Chem 275: 271-278.
115. Letessier A, Sircoulomb F, Ginestier C, Cervera N, Monville F, Gelsi- Boyer V et al. (2006). Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers. BMC Cancer 6: 245.
116. Li C, Wong P, Pan T, Xiao F, Yin S, Chang B et al. (2007). Normal cellular prion protein is a ligand of selectins: binding requires Le(X) but is inhibited by sLe(X). Biochem J 406: 333-341.
117. Li C, Yu S, Nakamura F, Yin S, Xu J, Petrolla AA et al. (2009). Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer. J Clin Invest 119: 2725-2736.
118. Li C, Yu S, Nakamura F, Pentikainen O, Singh N, Yin S et al. (2010). Pro-prion binds filamin A facilitating its interaction with integrin b1 and contributes to melanomagenesis. J Biol Chem (e-pub ahead of print 21 July 2010).
119. Li D, Xie K, Wolff R, Abbruzzese JL. (2004). Pancreatic cancer. Lancet 363: 1049-1057.
120. Li M, Li C, Weingarten P, Bunzow JR, Grandy DK, Zhou QY. (2002). Association of dopamine D(3) receptors with actin-binding protein 280 (ABP-280). Biochem Pharmacol 63: 859-863.
121. Li R, Liu T, Wong BS, Pan T, Morillas M, Swietnicki W et al. (2000). Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J Mol Biol 301: 567-573.
122. Li R, Liu T, Yoshihiro F, Trat-Lehmann M, Obrenovich M, Kuekrek H et al. (2003). On the same cell type GPI-anchored normal cellular prion and DAF protein exhibit different biological properties. Biochem Biophys Res Com 303: 446-451.
123. Li X, Lee NK, Ye YW, Waber PG, Schweitzer C, Cheng QC et al. (1994). Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer. J Natl Cancer Inst 86: 1524-1529.
124. Liang J, Ge F, Guo C, Luo G, Wang X, Han G et al. (2009). Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells. FEBS J 276: 685-694.
125. Lin M, Smith LT, Smiraglia DJ, Kazhiyur-Mannar R, Lang JC, Schuller DE et al. (2006). DNA copy number gains in head and neck squamous cell carcinoma. Oncogene 25: 1424-1433.
126. Lin R, Karpa K, Kabbani N, Goldman-Rakic P, Levenson R. (2001). Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A. Proc Natl Acad Sci USA 98: 5258-5263.
127. Lindholm PM, Salmenkivi K, Vauhkonen H, Nicholson AG, Anttila S, Kinnula VL et al. (2007). Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH. Cytogenet Genome Res 119: 46-52.
128. Liu ET. (2008). Functional genomics of cancer. Curr Opin Genet Dev 18: 251-256.
129. Liu G, Thomas L, Warren RA, Enns CA, Cunningham CC, Hartwig JH et al. (1997). Cytoskeletal protein ABP-280 directs the intracellular trafficking of furin and modulates proprotein processing in the endocytic pathway. J Cell Biol 139: 1719-1733.
130. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ et al. (2003). Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63: 2649-2657.
131. Loo DT, Kanner SB, Aruffo A. (1998). Filamin binds to the cytoplasmic domain of the beta1-integrin. Identification of amino acids responsible for this interaction. J Biol Chem 273: 23304-23312.
132. Loukopoulos P, Shibata T, Katoh H, Kokubu A, Sakamoto M, Yamazaki K et al. (2007). Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome. Cancer Sci 98: 392-400.
133. Loy CJ, Sim KS, Yong EL. (2003). Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc Natl Acad Sci USA 100: 4562-4567.
134. Lu J, Sheen V. (2005). Periventricular heterotopia. Epilepsy Behav 7: 143-149.
135. Luo BH, Carman CV, Springer TA. (2007). Structural basis of integrin regulation and signaling. Annu Rev Immunol 25: 619-647.
136. Ma J, Gao M, Lu Y, Feng X, Zhang J, Lin D et al. (2006). Gain of 1q25-32, 12q23-24.3, and 17q12-22 facilitates tumorigenesis and progression of human squamous cell lung cancer. J Pathol 210: 205-213.
137. Maeda Y, Ashida H, Kinoshita T. (2006). CHO glycosylation mutants: GPI anchor. Methods Enzymol 416: 182-205.
138. Mahfoud R, Garmy N, Maresca M, Yahi N, Puigserver A, Fantini J. (2002). Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins. J Biol Chem 277: 11292-11296.
139. Mani K, Cheng F, Havsmark B, Jonsson M, Belting M, Fransson LA. (2003). Prion, amyloid beta-derived Cu(II) ions, or free Zn(II) ions support S-nitroso-dependent autocleavage of glypican-1 heparan sulfate. J Biol Chem 278: 38956-38965.
140. Maqani N, Belkhiri A, Moskaluk C, Knuutila S, Dar AA, El-Rifai W. (2006). Molecular dissection of 17q12 amplicon in upper gastrointestinal adenocarcinomas. Mol Cancer Res 4: 449-455.
141. Mastracci TL, Shadeo A, Colby SM, Tuck AB, OMalley FP, Bull SB et al. (2006). Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast. Genes Chromosomes Cancer 45: 1007-1017.
142. Mhawech-Fauceglia P, Odunsi K, Dim D, Nowak N, Lele S, Cheney RT et al. (2008). Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma: mystery resolved? Int J Gynecol Pathol 27: 539-546.
143. Millhauser GL. (2007). Copper and the prion protein: methods, structures, function, and disease. Annu Rev Phys Chem 58: 299-320.
144. Miozzo M, Dalpra L, Riva P, Volonta M, Macciardi F, Pericotti S et al. (2000). A tumor suppressor locus in familial and sporadic chordoma maps to 1p36. Int J Cancer 87: 68-72.
145. Miyoshi E, Moriwaki K, Nakagawa T. (2008). Biological function of fucosylation in cancer biology. J Biochem 143: 725-729.
146. Morel E, Fouquet S, Strup-Perrot C, Pichol Thievend C, Petit C, Loew D et al. (2008). The cellular prion protein PrP(c) is involved in the proliferation of epithelial cells and in the distribution of junctionassociated proteins. PLoS One 3: e3000.
147. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM et al. (2000). Signal transduction through prion protein. Science 289: 1925-1928.
148. Muller PA, Caswell PT, Doyle B, Iwanicki MP, Tan EH, Karim S et al. (2009). Mutant p53 drives invasion by promoting integrin recycling. Cell 139: 1327-1341.
149. Myllykangas S, Junnila S, Kokkola A, Autio R, Scheinin I, Kiviluoto T et al. (2008). Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes. Int J Cancer 123: 817-825.
150. Naghibalhossaini F, Yoder AD, Tobi M, Stanners CP. (2007). Evolution of a tumorigenic property conferred by glycophosphatidyl- inositol membrane anchors of carcinoembryonic antigen gene family members during the primate radiation. Mol Biol Cell 18: 1366-1374.
151. Nagpal JK, Dasgupta S, Jadallah S, Chae YK, Ratovitski EA, Toubaji A et al. (2008). Profiling the expression pattern of GPI transamidase complex subunits in human cancer. Mod Pathol 21: 979-991.
152. Nakamura F, Osborn TM, Hartemink CA, Hartwig JH, Stossel TP. (2007). Structural basis of filamin A functions. J Cell Biol 179: 1011-1025.
153. Nakamura F, Pudas R, Heikkinen O, Permi P, Kilpelainen I, Munday AD et al. (2006). The structure of the GPIb-filamin A complex. Blood 107: 1925-1932.
154. Nakanishi H, Matsumoto S, Iwakawa R, Kohno T, Suzuki K, Tsuta K et al. (2009). Whole genome comparison of allelic imbalance between noninvasive and invasive small-sized lung adenocarcinomas. Cancer Res 69: 1615-1623.
155. Narang HK, Dagdanova A, Xie Z, Yang Q, Chen SG. (2005). Sensitive detection of prion protein in human urine. Exp Biol Med (Maywood) 230: 343-349.
156. Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, Rao PH et al. (2007). Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer 46: 373-384.
157. Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, Clemmer V et al. (2005). High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res 7: R1186-R1198.
158. Nicholson TB, Stanners CP. (2007). Identification of a novel functional specificity signal within the GPI anchor signal sequence of carcinoembryonic antigen. J Cell Biol 177: 211-218.
159. Nomachi A, Nishita M, Inaba D, Enomoto M, Hamasaki M, Minami Y. (2008). Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A. J Biol Chem 283: 27973-27981.
160. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng SW, Cravatt BF. (2010). Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140: 49-61
161. Notterman DA, Alon U, Sierk AJ, Levine AJ. (2001). Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61: 3124-3130.
162. Nowak NJ, Gaile D, Conroy JM, McQuaid D, Cowell J, Carter R et al. (2005). Genome-wide aberrations in pancreatic adenocarcinoma. Cancer Genet Cytogenet 161: 36-50.
163. OConnell MP, Fiori JL, Baugher KM, Indig FE, French AD, Camilli TC et al. (2009). Wnt5A activates the calpain-mediated cleavage of filamin A. J Invest Dermatol 129: 1782-1789.
164. Ohta Y, Suzuki N, Nakamura S, Hartwig JH, Stossel TP. (1999). The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci USA 96: 2122-2128.
165. Onoprishvili I, Andria ML, Kramer HK, Ancevska-Taneva N, Hiller JM, Simon EJ. (2003). Interaction between the mu opioid receptor and filamin A is
166. Ottenhof NA, Milne AN, Morsink FH, Drillenburg P, Ten Kate FJ, Maitra A et al. (2009). Pancreatic intraepithelial neoplasia and pancreatic tumorigenesis: of mice and men. Arch Pathol Lab Med 133: 375-381.
167. Paitel E, Sunyach C, Alves da Costa C, Bourdon JC, Vincent B, Checler F. (2004). Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels. J Biol Chem 279: 612-618.
168. Paladino S, Lebreton S, Tivodar S, Campana V, Tempre R, Zurzolo C. (2008). Different GPI-attachment signals affect the oligomerisation of GPI-anchored proteins and their apical sorting. J Cell Sci 121: 4001-4007.
169. Pan T, Wong BS, Liu T, Li R, Petersen RB, Sy MS. (2002). Cellsurface prion protein interacts with glycosaminoglycans. Biochem J 368: 81-90.
170. Peris K, Keller G, Chimenti S, Amantea A, Kerl H, Hofler H. (1995). Microsatellite instability and loss of heterozygosity in melanoma. J Invest Dermatol 105: 625-628.
171. Prusiner SB. (1982). Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144.
172. Prusiner SB. (1998). Prions. Proc Nat Acad Sci USA 95: 13363-13383.
173. Ravid D, Chuderland D, Landsman L, Lavie Y, Reich R, Liscovitch M. (2008). Filamin A is a novel caveolin-1-dependent target in IGFI- stimulated cancer cell migration. Exp Cell Res 314: 2762-2773.
174. Robertson SP. (2005). Filamin A: phenotypic diversity. Curr Opin Genet Dev 15: 301-307.
175. Sahar S, Sassone-Corsi P. (2009). Metabolism and cancer: the circadian clock connection. Nat Rev Cancer 9: 886-896.
176. Saito S, Ghosh M, Morita K, Hirano T, Miwa M, Todoroki T. (2006). The genetic differences between gallbladder and bile duct cancer cell lines. Oncol Rep 16: 949-956.
177. Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C. (2006). Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 24: 778-789.
178. Sasaki A, Masuda Y, Ohta Y, Ikeda K, Watanabe K. (2001). Filamin associates with Smads and regulates transforming growth factorbeta signaling. J Biol Chem 276: 17871-17877.
179. Schmitt-Ulms G, Hansen K, Liu J, Cowdrey C, Yang J, DeArmond SJ et al. (2004). Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues. Nat Biotechnol 22: 724-731.
180. Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ et al. (2001). Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 314: 1209-1225.
181. Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A et al. (2008). Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer 47: 755-765.
182. Screaton RA, DeMarte L, Draber P, Stanners CP. (2000). The specificity for the differentiation blocking activity of carcinoembryonic antigen resides in its glycophosphatidyl-inositol anchor. J Cell Biol 150: 613-626.
183. Seck T, Baron R, Horne WC. (2003). Binding of filamin to the Cterminal tail of the calcitonin receptor controls recycling. J Biol Chem 278: 10408-10416.
184. Selvarajah S, Yoshimoto M, Ludkovski O, Park PC, Bayani J, Thorner P et al. (2008). Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH. Cytogenet Genome Res 122: 5-15.
185. Sharma CP, Ezzell RM, Arnaout MA. (1995). Direct interaction of filamin (ABP-280) with the beta 2-integrin subunit CD18. J Immunol 154: 3461-3470.
186. Sharom FJ, Lehto MT. (2002). Glycosylphosphatidylinositol-anchored proteins: structure, function, and cleavage by phosphatidylinositol-specific phospholipase C. Biochem Cell Biol 80: 535-549.
187. Shi C, Daniels JA, Hruban RH. (2008). Molecular characterization of pancreatic neoplasms. Adv Anat Pathol 15: 185-195.
188. Shivapurkar N, Sood S, Wistuba II, Virmani AK, Maitra A, Milchgrub S et al. (1999). Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. Cancer Res 59: 3576-3580.
189. Sibley K, Bell S, Knowles MA. (2000). Redefining a critical region of LOH on 4p16.3 in bladder cancer. Genes Chromosomes Cancer 29: 378-379.
190. Simoneau S, Haik S, Leucht C, Dormont D, Deslys JP, Weiss S et al. (2003). Different isoforms of the non-integrin laminin receptor are present in mouse brain and bind PrP. Biol Chem 384: 243-246.
191. Skawran B, Steinemann D, Weigmann A, Flemming P, Becker T, Flik J et al. (2008). Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions. Mod Pathol 21: 505-516.
192. Spielhaupter C, Schatzl HM. (2001). PrPC directly interacts with proteins involved in signaling pathways. J Biol Chem 276: 44604-44612.
193. Stanford JL, FitzGerald LM, McDonnell SK, Carlson EE, McIntosh LM, Deutsch K et al. (2009). Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage. Hum Mol Genet 18: 1839-1848.
194. Steele AD, Zhou Z, Jackson WS, Zhu C, Auluck P, Moskowitz MA et al. (2009). Context dependent neuroprotective properties of prion protein (PrP). Prion 3: 240-249.
195. Stossel TP, Condeelis J, Cooley L, Hartwig JH, Noegel A, Schleicher M et al. (2001). Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol 2: 138-145.
196. Sun J, Purcell L, Gao Z, Isaacs SD, Wiley KE, Hsu FC et al. (2008). Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans. Prostate 68: 691-697.
197. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S et al. (2006). Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287-300.
198. Sverdlov M, Shinin V, Place AT, Castellon M, Minshall RD. (2009). Filamin A regulates caveolae internalization and trafficking in endothelial cells. Mol Biol Cell 20: 4531-4540.
199. Taylor DR, Hooper NM. (2006). The prion protein and lipid rafts. Mol Membr Biol 23: 89-99.
200. Tenesa A, Farrington SM, Prendergast JG, Porteous ME, Walker M, Haq N et al. (2008). Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 40: 631-637.
201. Thelin WR, Chen Y, Gentzsch M, Kreda SM, Sallee JL, Scarlett CO et al. (2007). Direct interaction with filamins modulates the stability and plasma membrane expression of CFTR. J Clin Invest 117: 364-374.
202. Thomassen M, Tan Q, Kruse TA. (2009). Gene expression metaanalysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis. Breast Cancer Res Treat 113: 239-249.
203. Tigges U, Koch B, Wissing J, Jockusch BM, Ziegler WH. (2003). The F-actin cross-linking and focal adhesion protein filamin A is a ligand and in vivo substrate for protein kinase C alpha. J Biol Chem 278: 23561-23569.
204. Tomar A, Schlaepfer DD. (2009). Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility. Curr Opin Cell Biol 21: 676-683.
205. Torring N, Borre M, Sorensen KD, Andersen CL, Wiuf C, Orntoft TF. (2007). Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array. Br J Cancer 96: 499-506.
206. Uhlen M, Bjorling E, Agaton C, Szigyarto CA, Amini B, Andersen E et al. (2005). A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 4: 1920-1932.
207. Vadlamudi RK, Li F, Adam L, Nguyen D, Ohta Y, Stossel TP et al. (2002). Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1. Nat Cell Biol 4: 681-690.
208. van Dartel M, Cornelissen PW, Redeker S, Tarkkanen M, Knuutila S, Hogendoorn PC et al. (2002). Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma. Cancer Genet Cytogenet 139: 91-96.
209. van Duin M, van Marion R, Vissers KJ, Hop WC, Dinjens WN, Tilanus HW et al. (2007). High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas. Cytogenet Genome Res 118: 130-137.
210. Vanden Bempt I, Vanhentenrijk V, Drijkoningen M, De Wolf-Peeters C. (2006). Comparative expressed sequence hybridization reveals differential gene expression in morphological breast cancer subtypes. J Pathol 208: 486-494.
211. Waneck GL, Stein ME, Flavell RA. (1988). Conversion of a PIanchored protein to an integral membrane protein by a single amino acid mutation. Science 241: 697-699.
212. Wang G, Zhao Y, Liu X, Wang L, Wu C, Zhang W et al. (2001). Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma. Genes Chromosomes Cancer 31: 221-227.
213. Wang Y, Kreisberg JI, Bedolla RG, Mikhailova M, deVere White RW, Ghosh PM. (2007). A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells. Oncogene 26: 6061-6070.
214. Wescott MP, Rustgi AK. (2008). Pancreatiic cancer: translating lessons from mouse models and hereditary syndromes. Cancer Prev Res (Phila Pa) 1: 503-506.
215. White GR, Varley JM, Heighway J. (1998). Isolation and characterization of a human homologue of the latrophilin gene from a region of 1p31.1 implicated in breast cancer. Oncogene 17: 3513-3519.
216. Williamson D, Pikovski I, Cranmer SL, Mangin P, Mistry N, Domagala T et al. (2002). Interaction between platelet glycoprotein Ibalpha and filamin-1 is essential for glycoprotein Ib/IX receptor anchorage at high shear. J Biol Chem 277: 2151-2159.
217. Wong N, Chan A, Lee SW, Lam E, To KF, Lai PB et al. (2003). Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression. J Hepatol 38: 298-306.
218. Woo MS, Ohta Y, Rabinovitz I, Stossel TP, Blenis J. (2004). Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin A on an important regulatory site. Mol Cell Biol 24: 3025-3035.
219. Wu G, Guo Z, Chatterjee A, Huang X, Rubin E, Wu F et al. (2006). Overexpression of glycosylphosphatidylinositol (GPI) transamidase subunits phosphatidylinositol glycan class T and/or GPI anchor attachment 1 induces tumorigenesis and contributes to invasion in human breast cancer. Cancer Res 66: 9829-9836.
220. Yan H, Bigner DD, Velculescu V, Parsons DW. (2009). Mutant metabolic enzymes are at the origin of gliomas. Cancer Res 69: 9157-9159.
221. Yin S, Fan X, Yu S, Li C, Sy MS. (2008). Binding of recombinant but not endogenous prion protein to DNA causes DNA internalization and expression in mammalian cells. J Biol Chem 283: 25446-25454.
222. Yu J, Zhou H, Jin Y, Bai J, Yu Y, Geng J et al. (2008). Three distinct regions of allelic deletion on chromosome 17 involved in sporadic gastric cancer. Hepatogastroenterology 55: 1487-1491.
223. Yue J, Wang Q, Lu H, Brenneman M, Fan F, Shen Z. (2009). The cytoskeleton protein filamin-A is required for an efficient recombinational DNA double strand break repair. Cancer Res 69: 7978-7985.
224. Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG, Kovacs G. (2009). High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer 9: 152.
225. Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R et al. (2002). Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 21: 3307-3316.
226. Zanusso G, Liu D, Ferrari S, Hegyi I, Yin X, Aguzzi A et al. (1998). Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci USA 95: 8812-8816.
227. Zhu TN, He HJ, Kole S, DSouza T, Agarwal R, Morin PJ et al. (2007). Filamin A-mediated down-regulation of the exchange factor Ras-GRF1 correlates with decreased matrix metalloproteinase-9 expression in human melanoma cells. J Biol Chem 282: 14816-14826.
228. Zielinski B, Gratias S, Toedt G, Mendrzyk F, Stange DE, Radlwimmer B et al. (2005). Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes Cancer 43: 294-301. (Pubitemid 40726874)